针对投资风险，超研股份提示说，本次投资周期较长，基金在运作过程中可能受宏观经济、行业周期、 投资标的、交易方案等多种因素的影响而致使基金总体收益水平存在不确定的风险；本次投资事项尚需 进行工商登记、基金备案等，具体实施情况（包括合伙企业的名称、注册地址等）和进度尚存在不确定 性。公司将密切关注合伙企业经营管理状况，以降低投资风险。 超研股份目前的产品主要为医用超声影像设备、X射线、工业无损检测设备。今年前三季度，超研股份 实现营业收入2.54亿元，净利润8894万元，同比分别下降2.9%和3.66%。 11月26日晚间，超研股份（301602）公告，为落实公司战略发展规划，充分借助专业投资机构的投资经 验及资源优势，加快推动公司产业布局优化，公司拟与专业投资机构共同投资设立广东粤财中瀛新兴产 业股权投资基金合伙企业（有限合伙）（暂定名，以下简称"合伙企业"或"基金"），合伙企业拟募集资 金10亿元，其中公司作为有限合伙人，拟以自有资金认缴5000万元，占比5%。 公告显示，12月26日，超研股份与粤财中垠、中银资本、广东产业发展基金、中银资产、松山湖产投母 基金共同签署了《广东粤财中瀛新兴产业股权投资基金合伙 ...

Group 1: Company Strategy and Focus Areas - The company aims to enhance its core competitiveness through industrial investments, focusing on the medical imaging and non-destructive testing sectors [2][3] - The company is actively seeking acquisition opportunities that align with its strategic development [2][3] - The company plans to expand its product portfolio through both depth and breadth, targeting cross-sector development [2][3] Group 2: Product Development and Market Position - The company has developed a portable multi-modal medical imaging system for emergency rescue applications, integrating portable DR and ultrasound devices [3][4] - The company’s industrial ultrasonic testing equipment is widely used in aerospace, petrochemicals, energy, and transportation sectors [4][5] - Key products include multi-modal medical imaging systems, specialized ultrasound diagnostic equipment, and automated non-destructive testing devices, which are expected to drive future revenue growth [5][6] Group 3: Research and Development - The company has participated in multiple national and provincial major research projects, with details disclosed in its prospectus and periodic reports [4][5] - The company has made advancements in AI-based breast cancer screening technology, enhancing the accuracy and efficiency of early detection [5][6] Group 4: Marketing and Sales Strategy - In 2025, the company will adjust its marketing strategy, focusing on major cities like Guangzhou, Shenzhen, Shanghai, and Beijing to strengthen its domestic and overseas marketing efforts [7][8] - The company aims to enhance its marketing network by attracting high-quality domestic and international distributors and improving local customer service capabilities [7][8] Group 5: Revenue Contribution - The sales revenue from surgical robots and automated non-destructive testing equipment constitutes a significant portion of the company's overall revenue [8]

证券代码：301602 证券简称：超研股份 汕头市超声仪器研究所股份有限公司 投资者关系活动记录表 编号：2025-002 答：您好，股票价格是多种因素综合影响的结果，公司一直以 提升经济效益为目标，重视公司市值成长，以期回报广大投资 者的信任。感谢您的关注! 4、请问公司预计未来业绩增长点会出在哪个方向？ 答：您好，公司未来的盈利增长将主要来源于将超声、射线、 人工智能技术与用户需求相结合不断推出的创新型产品。如公 司在国内率先提出了医用超声扫描标准化和诊断智能化的解 决方案，并已经应用于智能乳腺全容积超声诊断系统等产品， 为超声产品在专科诊疗领域推广应用带来了广阔的增长空间； 将可免防护便携式 DR 与掌上超声相结合，为应急救援领域等 带来全新的多模态影像诊断工具。在无损检测领域，2024 年 推出了爬壁机器人检测系统，能够代替人工在特殊环境中进行 超声检测和视觉检测，降低作业风险也提高了检测效率和检测 质量。以上这些都是未来公司业绩新的增长点。感谢您的关注！ 5、董事长好！公司刚上市半年，7 月份就解禁 350 多万股会 对目前的股价有重大影响吗？ 答：您好，股票价格受宏观环境、行业政策、投资者偏好等多 ...